Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Rubinstein Julie sold 35,643 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Oct 19 to Oct 21, 2026 · Filed Oct 21, 2026
From Oct 19 to Oct 21, 2026, Rubinstein Julie (President and COO) sold 35,643 Adaptive Biotechnologies Corporation shares at an average US$24.66 for US$879K under a trading plan, leaving 377,802 shares. Filed Oct 21, 2026 (Form 4).
- Sold
- 35,643 shares
- Price
- US$24.66 average (US$24.05 to US$25.57)
- Value
- US$879K
- Holding after
- 377,802 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 19, 2026 | Common Stock | Sale | 11,881 | US$24.05 | 377,802 | Direct |
| Oct 20, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 20, 2026 | Common Stock | Sale | 11,781 | US$24.53 | 377,902 | Direct |
| Oct 20, 2026 | Common Stock | Sale | 100 | US$24.85 | 377,802 | Direct |
| Oct 21, 2026 | Common Stock | Option exercise | 11,881 | US$12.14 | 389,683 | Direct |
| Oct 21, 2026 | Common Stock | Sale | 5,999 | US$25.25 | 383,684 | Direct |
| Oct 21, 2026 | Common Stock | Sale | 5,882 | US$25.57 | 377,802 | Direct |
Source
Download original · View original at SEC
Related
- Adaptive Biotechnologies Corporation
- Rubinstein Julie
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026
- Form 4 · Rubinstein Julie · Apr 29, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Lo Francis · Oct 5, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026